Early Intensive DMT Use May Prevent Greater Long-term Disability in RRMS

June 22, 2021 09:30pm

Early intensive treatment was more efficacious at slowing disease accumulation in patients with relapsing-remitting multiple sclerosis (RRMS) vs initiating therapy with a moderate-efficacy disease-modifying treatment (DMT) prior to switching to a higher-efficacy DMT.

Work Exposure to Paraquat Not Associated With Increased Risk of Parkinson Disease, Mortality
Older Adults With COPD Report Barriers, Motivators to Using Wearable Activity Trackers
Dr Robert Gabbay Previews the ADA’s 81st Scientific Sessions
Understanding the Intersection Between COVID-19, Firearm Ownership, and Suicide